Narayana Hrudayalaya Q4 Profit Up 16% YoY, Margins Strengthen

$NH 📰 Key Highlights Net Profit: ₹2.28B vs ₹1.97B YoY → +16% growth Revenue: ₹25.9B vs ₹14.7B YoY → +76% growth EBITDA: ₹7.55B vs ₹3.85B YoY → +96% growth EBITDA Margin: 29.11% vs 26.1% YoY → margin expansion of ~301 bps 📊 Fundamentals & Ratios PE Ratio (TTM): ~26x (slightly below healthcare sector average ~30x). ROE: ~15% (improved from ~12% last year). Debt-to-Equity: ~0.4 (manageable leverage). Dividend Yield: ~0.9%. 🏥 Business Focus & Projects Expanding hospital network in Bengaluru, Kolkata, and Mumbai. Strong growth in cardiac care, oncology, and transplant services. Focus on affordable healthcare delivery models. Investments in digital health, telemedicine, and AI-driven diagnostics. ⚠️ Risks Regulatory changes in healthcare pricing and insurance coverage. High operating costs in hospital expansion. Dependence on specialized services (cardiac, oncology) for revenue. Competition from peers like Apollo Hospitals, Fortis, and Max Healthcare. 📈 Outlook Strong revenue growth driven by higher patient volumes and new hospital launches. Margin expansion trend encouraging for sustained profitability. Narayana Hrudayalaya positioning itself as a leading provider of affordable, high-quality healthcare in India.